Trials / Completed
CompletedNCT01728610
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms (IBS-2)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 391 (actual)
- Sponsor
- Danisco · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to analyse the effect of a probiotic supplement on functional intestinal symptoms among subjects diagnosed with irritable bowel syndrome (IBS).
Detailed description
The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on functional intestinal symptoms among subjects diagnosed with IBS according to Rome III criteria. Subjective assessment of bowel symptoms, quality of life, anxiety and depression and adequate relief will be assessed as with questionnaires as outcome measures. The intestinal microbiota will be analysed from faecal samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic (Active high) | Higher dose of probiotic supplement |
| DIETARY_SUPPLEMENT | Probiotic (Active low) | Lower dose of probiotic supplement |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2012-11-20
- Last updated
- 2016-01-26
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT01728610. Inclusion in this directory is not an endorsement.